Airtran Announced Positive
Seattle Genetics Inc. announced positive clinical data for treatment of patients with Hodgkin’s lymphoma, which no treatment. The drug, in partnership with Takeda Pharmaceutical Co. (TKPYY, 4502.TO) is an antibody, a drug that kills the cells, a type of antibody to the drug targets the cancer, binds it kills.
No comments:
Post a Comment